Page 6 - Ipid Management News Today

The prevalence of elevated low-density lipoprotein cholesterol has declined recently, but millions of Americans still have levels for which treatment is recommended or should be considered and many remain untreated.

No racial or ethnic disparities in long-term adverse effects or cardiovascular mortality were seen among women with obstructive coronary artery disease treated in university or academic centers.

The latest study of statins and diabetes risk points to a small increased risk for new-onset diabetes with rosuvastatin vs atorvastatin, but experts advise caution in interpreting the results.

Older patients with higher triglyceride levels, mostly within the normal to high range, had lower risk of dementia and slower cognitive decline over time than those with lower triglyceride levels.

A plant-based dietary pattern that includes cholesterol-lowering foods and nutrients is associated with lower risk for cardiovascular disease and stroke, a new study suggests.

Data from four tirzepatide pivotal trials in people with type 2 diabetes showed ≥15% weight loss in 25% of those on tirzepatide, with seven factors significantly linked with greater weight loss.

Ordering inappropriate cardiac imaging can set off a cascade of unnecessary tests, referrals, and treatment.

An investigational dual PPAR agonist modifies Alzheimers pathology and shows cognitive benefit in adults with mild-to-moderate disease and high plasma pTau-217 ratio, early data show.

Hypertension, obesity, diabetes, and other common risk factors for dementia pose an even greater risk to South Asian and Black individuals compared to White persons.

Evidence showing the SARS-CoV-2 virus directly infects coronary atherosclerotic plaques, causing a persistent inflammatory response, may lead to new approaches for managing patients after infection.